Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,208 | -58,235 | -36,189 | -16,599 | -12,106 |
| Depreciation Amortization | 309 | 897 | 641 | 416 | 204 |
| Accounts receivable | N/A | N/A | -6,000 | N/A | N/A |
| Accounts payable and accrued liabilities | -359 | 1,232 | 867 | 2,749 | 2,557 |
| Other Working Capital | -8,386 | -11,345 | -13,572 | -7,704 | -2,961 |
| Other Operating Activity | 3,979 | 7,924 | 11,628 | 7 | -1,307 |
| Operating Cash Flow | $-29,665 | $-59,527 | $-42,625 | $-21,131 | $-13,613 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,561 | -1,837 | -1,141 | -367 | -165 |
| Purchase Of Investment | -54,571 | -372,361 | -267,976 | -86,117 | -19,868 |
| Sale Of Investment | 44,415 | 190,764 | 130,890 | 100,471 | 40,645 |
| Investing Cash Flow | $-11,717 | $-183,434 | $-138,227 | $13,987 | $20,612 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 265 | 1,058 | 957 | 764 | 439 |
| Other Financing Activity | -8 | 356,267 | 356,488 | 28,901 | 29,972 |
| Financing Cash Flow | $257 | $357,325 | $357,445 | $29,665 | $30,411 |
| Beginning Cash Position | 145,024 | 30,660 | 30,660 | 30,660 | 30,660 |
| End Cash Position | 103,899 | 145,024 | 207,253 | 53,181 | 68,070 |
| Net Cash Flow | $-41,125 | $114,364 | $176,593 | $22,521 | $37,410 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,665 | -59,527 | -42,625 | -21,131 | -13,613 |
| Capital Expenditure | -1,561 | -1,837 | -1,141 | -367 | -165 |
| Free Cash Flow | -31,226 | -61,364 | -43,766 | -21,498 | -13,778 |